Damora Therapeutics grants new hires options for 135,400 shares at $28.18 each
DMRA•New hire option grants
Damora Therapeutics granted options covering 135,400 ordinary shares to three newly hired, non-executive employees on Sept. 1, 2026.
The options carry a 10-year term with an exercise price of USD 28.18 per share.
Vesting starts with 25% after one year, then continues in equal monthly installments over the next 36 months.
